IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Briacell Therapeutics Corp

CUSIP: 107930959 | 4 institutional holders

Quarters

Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile